Lisa Hines
Concepts (352)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Breast Neoplasms | 52 | 2024 | 2133 | 3.670 |
Why?
| Receptors, Estrogen | 12 | 2024 | 422 | 1.740 |
Why?
| Receptors, Progesterone | 8 | 2024 | 341 | 1.290 |
Why?
| Genetic Predisposition to Disease | 23 | 2017 | 2274 | 1.150 |
Why?
| Menopause | 9 | 2024 | 297 | 1.120 |
Why?
| Case-Control Studies | 37 | 2024 | 3378 | 0.960 |
Why?
| Polymorphism, Single Nucleotide | 21 | 2022 | 2060 | 0.850 |
Why?
| Receptor, ErbB-2 | 2 | 2024 | 326 | 0.800 |
Why?
| Alcohol Drinking | 9 | 2017 | 765 | 0.780 |
Why?
| Emigrants and Immigrants | 1 | 2023 | 122 | 0.700 |
Why?
| Risk Factors | 39 | 2024 | 9786 | 0.680 |
Why?
| Middle Aged | 58 | 2024 | 31136 | 0.590 |
Why?
| Coronary Disease | 3 | 2005 | 385 | 0.530 |
Why?
| Adult | 56 | 2024 | 35599 | 0.510 |
Why?
| Aged | 47 | 2024 | 22061 | 0.510 |
Why?
| Adenylyl Cyclases | 2 | 2006 | 83 | 0.500 |
Why?
| Parity | 5 | 2024 | 120 | 0.490 |
Why?
| Alcohol Dehydrogenase | 3 | 2005 | 16 | 0.480 |
Why?
| Suicide, Attempted | 1 | 2017 | 356 | 0.430 |
Why?
| Female | 67 | 2024 | 68734 | 0.430 |
Why?
| Genetics | 1 | 2014 | 25 | 0.430 |
Why?
| Substance-Related Disorders | 2 | 2017 | 1020 | 0.430 |
Why?
| Science | 1 | 2014 | 50 | 0.410 |
Why?
| Faculty | 1 | 2014 | 137 | 0.400 |
Why?
| Depressive Disorder, Major | 2 | 2006 | 345 | 0.390 |
Why?
| Suicidal Ideation | 1 | 2017 | 492 | 0.380 |
Why?
| Reproductive History | 2 | 2024 | 18 | 0.370 |
Why?
| Postmenopause | 4 | 2014 | 349 | 0.360 |
Why?
| Genotype | 14 | 2016 | 1833 | 0.360 |
Why?
| Energy Metabolism | 4 | 2022 | 875 | 0.350 |
Why?
| Mental Health | 1 | 2017 | 688 | 0.350 |
Why?
| Phenotype | 4 | 2011 | 3075 | 0.350 |
Why?
| Mammography | 2 | 2009 | 146 | 0.340 |
Why?
| Healthcare Disparities | 9 | 2016 | 578 | 0.330 |
Why?
| Breast Feeding | 3 | 2019 | 423 | 0.330 |
Why?
| Humans | 72 | 2024 | 129625 | 0.330 |
Why?
| Biomarkers, Tumor | 5 | 2024 | 1164 | 0.330 |
Why?
| Vocabulary, Controlled | 1 | 2010 | 45 | 0.320 |
Why?
| Polymorphism, Genetic | 4 | 2014 | 637 | 0.320 |
Why?
| Alcoholism | 4 | 2017 | 765 | 0.310 |
Why?
| California | 3 | 2024 | 400 | 0.300 |
Why?
| Sex Characteristics | 4 | 2006 | 736 | 0.300 |
Why?
| Students | 1 | 2014 | 582 | 0.300 |
Why?
| San Francisco | 4 | 2023 | 51 | 0.290 |
Why?
| Neoplasms, Hormone-Dependent | 1 | 2008 | 38 | 0.290 |
Why?
| Diet | 5 | 2015 | 1213 | 0.280 |
Why?
| Aldehyde Oxidoreductases | 3 | 2004 | 27 | 0.280 |
Why?
| Estrogen Replacement Therapy | 1 | 2008 | 137 | 0.270 |
Why?
| Hormones | 2 | 2012 | 141 | 0.260 |
Why?
| United States | 15 | 2024 | 13871 | 0.250 |
Why?
| Mexico | 5 | 2019 | 191 | 0.250 |
Why?
| Odds Ratio | 7 | 2018 | 1019 | 0.240 |
Why?
| Lipoproteins, HDL | 1 | 2005 | 85 | 0.230 |
Why?
| Synoviocytes | 1 | 2024 | 11 | 0.230 |
Why?
| Menstruation | 2 | 2021 | 44 | 0.230 |
Why?
| Transforming Growth Factor beta | 3 | 2013 | 460 | 0.220 |
Why?
| Multiplex Polymerase Chain Reaction | 1 | 2024 | 51 | 0.220 |
Why?
| Indians, North American | 6 | 2015 | 601 | 0.220 |
Why?
| Life Style | 3 | 2015 | 461 | 0.220 |
Why?
| Mass Screening | 2 | 2009 | 1190 | 0.210 |
Why?
| Algorithms | 2 | 2010 | 1616 | 0.200 |
Why?
| Aldehyde Dehydrogenase | 2 | 2017 | 101 | 0.200 |
Why?
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2022 | 38 | 0.190 |
Why?
| Blood Platelets | 1 | 2005 | 382 | 0.190 |
Why?
| Health Status Disparities | 4 | 2017 | 256 | 0.190 |
Why?
| Southwestern United States | 5 | 2015 | 90 | 0.190 |
Why?
| Aged, 80 and over | 13 | 2024 | 7052 | 0.190 |
Why?
| Genetic Association Studies | 4 | 2022 | 362 | 0.180 |
Why?
| Gram-Negative Bacterial Infections | 1 | 2021 | 45 | 0.180 |
Why?
| Adiposity | 2 | 2016 | 504 | 0.170 |
Why?
| Methicillin-Resistant Staphylococcus aureus | 2 | 2014 | 220 | 0.170 |
Why?
| Logistic Models | 7 | 2020 | 1986 | 0.170 |
Why?
| Cholesterol, HDL | 1 | 2001 | 205 | 0.170 |
Why?
| Immunohistochemistry | 1 | 2024 | 1685 | 0.170 |
Why?
| Age Factors | 6 | 2018 | 3152 | 0.160 |
Why?
| Menarche | 1 | 2020 | 59 | 0.160 |
Why?
| Genetic Variation | 3 | 2014 | 939 | 0.160 |
Why?
| Insulin-Like Growth Factor I | 1 | 2022 | 306 | 0.160 |
Why?
| Smoking | 3 | 2015 | 1500 | 0.160 |
Why?
| Bacteremia | 1 | 2021 | 194 | 0.160 |
Why?
| Staphylococcal Infections | 2 | 2014 | 389 | 0.150 |
Why?
| Premenopause | 4 | 2022 | 120 | 0.150 |
Why?
| Anti-Bacterial Agents | 3 | 2024 | 1705 | 0.150 |
Why?
| Young Adult | 11 | 2021 | 12455 | 0.150 |
Why?
| Myocardial Infarction | 2 | 2004 | 1021 | 0.140 |
Why?
| Body Size | 2 | 2015 | 104 | 0.140 |
Why?
| Pregnancy | 4 | 2024 | 6417 | 0.140 |
Why?
| Incidence | 6 | 2016 | 2641 | 0.130 |
Why?
| Carcinoma, Ductal, Breast | 1 | 2016 | 80 | 0.130 |
Why?
| Body Mass Index | 7 | 2015 | 2274 | 0.130 |
Why?
| Cigarette Smoking | 1 | 2017 | 91 | 0.120 |
Why?
| Matrix Metalloproteinases | 2 | 2013 | 90 | 0.120 |
Why?
| Triple Negative Breast Neoplasms | 1 | 2018 | 193 | 0.120 |
Why?
| Mitogen-Activated Protein Kinases | 2 | 2015 | 312 | 0.120 |
Why?
| Socioeconomic Factors | 2 | 2017 | 1213 | 0.120 |
Why?
| Arachidonate 12-Lipoxygenase | 1 | 2014 | 17 | 0.120 |
Why?
| Microbial Sensitivity Tests | 3 | 2024 | 348 | 0.120 |
Why?
| Prostaglandin-Endoperoxide Synthases | 1 | 2014 | 72 | 0.110 |
Why?
| Aromatase | 1 | 2014 | 31 | 0.110 |
Why?
| Waist Circumference | 1 | 2014 | 138 | 0.110 |
Why?
| Selenoprotein P | 1 | 2013 | 3 | 0.110 |
Why?
| Oxidative Stress | 2 | 2013 | 1266 | 0.110 |
Why?
| Immunity | 1 | 2014 | 138 | 0.110 |
Why?
| Postpartum Period | 2 | 2022 | 333 | 0.110 |
Why?
| Models, Educational | 1 | 2014 | 89 | 0.100 |
Why?
| Endonucleases | 1 | 2013 | 28 | 0.100 |
Why?
| Schizosaccharomyces | 1 | 2014 | 58 | 0.100 |
Why?
| Telomere Homeostasis | 1 | 2013 | 29 | 0.100 |
Why?
| Social Justice | 1 | 2013 | 76 | 0.100 |
Why?
| Women's Health | 3 | 2016 | 364 | 0.100 |
Why?
| Neoplasms, Glandular and Epithelial | 1 | 2013 | 35 | 0.100 |
Why?
| Male | 13 | 2024 | 63670 | 0.100 |
Why?
| Infection Control | 1 | 2014 | 141 | 0.100 |
Why?
| Genetics, Population | 1 | 2014 | 200 | 0.100 |
Why?
| Transcription Factor 7-Like 2 Protein | 1 | 2012 | 22 | 0.100 |
Why?
| Tobacco Smoke Pollution | 1 | 2015 | 231 | 0.100 |
Why?
| Inflammation | 2 | 2014 | 2750 | 0.100 |
Why?
| Interleukins | 1 | 2014 | 241 | 0.100 |
Why?
| C-Reactive Protein | 1 | 2014 | 400 | 0.100 |
Why?
| Bone Morphogenetic Proteins | 1 | 2012 | 129 | 0.100 |
Why?
| Prognosis | 5 | 2022 | 3774 | 0.100 |
Why?
| Intercellular Signaling Peptides and Proteins | 1 | 2013 | 374 | 0.090 |
Why?
| Genome | 1 | 2014 | 278 | 0.090 |
Why?
| Neovascularization, Pathologic | 1 | 2013 | 296 | 0.090 |
Why?
| Cross-Sectional Studies | 2 | 2017 | 5075 | 0.090 |
Why?
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2014 | 338 | 0.090 |
Why?
| Registries | 3 | 2018 | 1899 | 0.090 |
Why?
| Aspirin | 1 | 2014 | 380 | 0.090 |
Why?
| Universities | 1 | 2014 | 409 | 0.090 |
Why?
| Polymerase Chain Reaction | 1 | 2014 | 1035 | 0.090 |
Why?
| Perception | 1 | 2014 | 344 | 0.090 |
Why?
| Obesity | 3 | 2016 | 2882 | 0.090 |
Why?
| Risk | 4 | 2015 | 855 | 0.090 |
Why?
| Dietary Fats | 2 | 2015 | 301 | 0.090 |
Why?
| Telomerase | 1 | 2013 | 234 | 0.090 |
Why?
| Telomere | 1 | 2013 | 233 | 0.090 |
Why?
| Research | 1 | 2014 | 419 | 0.090 |
Why?
| Cross Infection | 1 | 2012 | 217 | 0.090 |
Why?
| Breast | 3 | 2017 | 153 | 0.080 |
Why?
| Anxiety | 1 | 2017 | 972 | 0.080 |
Why?
| Risk Assessment | 4 | 2022 | 3262 | 0.080 |
Why?
| RNA | 1 | 2016 | 882 | 0.080 |
Why?
| Mammary Glands, Human | 1 | 2010 | 64 | 0.080 |
Why?
| Population Surveillance | 3 | 2018 | 439 | 0.080 |
Why?
| Gene-Environment Interaction | 3 | 2015 | 185 | 0.080 |
Why?
| Weight Gain | 1 | 2013 | 509 | 0.080 |
Why?
| Mammary Glands, Animal | 1 | 2010 | 128 | 0.080 |
Why?
| Macrophage Activation | 1 | 2010 | 189 | 0.080 |
Why?
| Natural Language Processing | 1 | 2010 | 94 | 0.070 |
Why?
| Transcription Factors | 2 | 2013 | 1647 | 0.070 |
Why?
| Depression | 1 | 2017 | 1317 | 0.070 |
Why?
| Follow-Up Studies | 4 | 2021 | 4894 | 0.070 |
Why?
| Proteomics | 2 | 2006 | 1055 | 0.070 |
Why?
| Liver | 1 | 2016 | 1842 | 0.070 |
Why?
| Research Design | 1 | 2014 | 1045 | 0.070 |
Why?
| Ovarian Neoplasms | 1 | 2013 | 484 | 0.070 |
Why?
| Collagen | 1 | 2010 | 435 | 0.070 |
Why?
| Family Health | 1 | 2008 | 198 | 0.070 |
Why?
| Chi-Square Distribution | 1 | 2008 | 515 | 0.070 |
Why?
| Neoplasm Staging | 3 | 2016 | 1282 | 0.070 |
Why?
| Homozygote | 2 | 2013 | 195 | 0.070 |
Why?
| Eye Proteins | 1 | 2007 | 89 | 0.070 |
Why?
| Colorado | 2 | 2014 | 4404 | 0.070 |
Why?
| Colorectal Neoplasms | 2 | 2006 | 749 | 0.070 |
Why?
| O(6)-Methylguanine-DNA Methyltransferase | 1 | 2006 | 6 | 0.070 |
Why?
| Cornea | 1 | 2007 | 128 | 0.060 |
Why?
| Biomarkers | 3 | 2010 | 3968 | 0.060 |
Why?
| Genetic Linkage | 1 | 2006 | 298 | 0.060 |
Why?
| Sensitivity and Specificity | 2 | 2008 | 1843 | 0.060 |
Why?
| DNA-Binding Proteins | 1 | 2013 | 1445 | 0.060 |
Why?
| Lens, Crystalline | 1 | 2007 | 123 | 0.060 |
Why?
| DNA, Complementary | 1 | 2006 | 270 | 0.060 |
Why?
| International Agencies | 1 | 2005 | 29 | 0.060 |
Why?
| Patient Compliance | 1 | 2009 | 565 | 0.060 |
Why?
| World Health Organization | 1 | 2005 | 110 | 0.060 |
Why?
| Giant Cell Tumor of Tendon Sheath | 1 | 2024 | 4 | 0.060 |
Why?
| Antioxidants | 1 | 2008 | 558 | 0.060 |
Why?
| Cataract | 1 | 2007 | 209 | 0.060 |
Why?
| Sex Distribution | 1 | 2005 | 360 | 0.050 |
Why?
| Cause of Death | 2 | 2016 | 395 | 0.050 |
Why?
| Gene Frequency | 1 | 2005 | 502 | 0.050 |
Why?
| Retinal Dehydrogenase | 2 | 2017 | 30 | 0.050 |
Why?
| Prevalence | 1 | 2010 | 2564 | 0.050 |
Why?
| Bacterial Typing Techniques | 2 | 2014 | 43 | 0.050 |
Why?
| Databases, Bibliographic | 1 | 2003 | 30 | 0.050 |
Why?
| Antidepressive Agents | 1 | 2005 | 229 | 0.050 |
Why?
| Pneumonia, Bacterial | 1 | 2024 | 115 | 0.050 |
Why?
| Soft Tissue Neoplasms | 1 | 2024 | 111 | 0.050 |
Why?
| Ohio | 2 | 2014 | 152 | 0.050 |
Why?
| Genome-Wide Association Study | 3 | 2015 | 1326 | 0.050 |
Why?
| Linear Models | 1 | 2005 | 819 | 0.050 |
Why?
| Signal Transduction | 5 | 2016 | 4931 | 0.050 |
Why?
| Amino Acid Sequence | 1 | 2006 | 2057 | 0.050 |
Why?
| Survival Analysis | 2 | 2017 | 1269 | 0.050 |
Why?
| Antimicrobial Stewardship | 1 | 2024 | 107 | 0.050 |
Why?
| Adolescent | 5 | 2021 | 20412 | 0.050 |
Why?
| Macrophages | 1 | 2010 | 1488 | 0.050 |
Why?
| Molecular Sequence Data | 1 | 2006 | 2835 | 0.050 |
Why?
| Homeostasis | 2 | 2016 | 605 | 0.050 |
Why?
| Diabetes Mellitus, Type 2 | 1 | 2016 | 2442 | 0.050 |
Why?
| Societies, Medical | 1 | 2005 | 744 | 0.050 |
Why?
| Mice, Transgenic | 1 | 2006 | 2128 | 0.050 |
Why?
| Blood Culture | 1 | 2021 | 20 | 0.050 |
Why?
| Hemostasis | 1 | 2001 | 80 | 0.050 |
Why?
| Age of Onset | 2 | 2016 | 495 | 0.040 |
Why?
| Gram-Negative Bacteria | 1 | 2021 | 69 | 0.040 |
Why?
| Survivors | 2 | 2016 | 460 | 0.040 |
Why?
| Isoenzymes | 1 | 2001 | 301 | 0.040 |
Why?
| Mice, Inbred C57BL | 2 | 2010 | 5455 | 0.040 |
Why?
| Neoplasm Invasiveness | 2 | 2016 | 481 | 0.040 |
Why?
| Predictive Value of Tests | 2 | 2022 | 1947 | 0.040 |
Why?
| Survival Rate | 2 | 2014 | 1872 | 0.040 |
Why?
| Ethanol | 1 | 2004 | 591 | 0.040 |
Why?
| Biomedical Research | 1 | 2005 | 640 | 0.040 |
Why?
| Proportional Hazards Models | 1 | 2022 | 1198 | 0.040 |
Why?
| Computational Biology | 1 | 2003 | 596 | 0.040 |
Why?
| Pneumonia | 1 | 2024 | 617 | 0.040 |
Why?
| Regression Analysis | 1 | 2001 | 997 | 0.040 |
Why?
| Genomics | 1 | 2003 | 718 | 0.040 |
Why?
| Animals | 5 | 2016 | 35391 | 0.040 |
Why?
| Lipids | 1 | 2001 | 627 | 0.040 |
Why?
| Cohort Studies | 2 | 2022 | 5426 | 0.040 |
Why?
| Rats, Inbred SHR | 1 | 2016 | 44 | 0.030 |
Why?
| Lod Score | 1 | 2016 | 66 | 0.030 |
Why?
| Gene Ontology | 1 | 2016 | 49 | 0.030 |
Why?
| Poultry | 1 | 2016 | 9 | 0.030 |
Why?
| Mice | 3 | 2010 | 16961 | 0.030 |
Why?
| Cholecystokinin | 1 | 2016 | 13 | 0.030 |
Why?
| Neuropeptide Y | 1 | 2016 | 14 | 0.030 |
Why?
| Area Under Curve | 1 | 2016 | 304 | 0.030 |
Why?
| Receptors, Ghrelin | 1 | 2016 | 8 | 0.030 |
Why?
| Red Meat | 1 | 2016 | 17 | 0.030 |
Why?
| Receptors, Leptin | 1 | 2016 | 23 | 0.030 |
Why?
| SEER Program | 1 | 2016 | 202 | 0.030 |
Why?
| Linkage Disequilibrium | 1 | 2016 | 257 | 0.030 |
Why?
| Survival | 1 | 2015 | 38 | 0.030 |
Why?
| Fishes | 1 | 2016 | 94 | 0.030 |
Why?
| Mitogen-Activated Protein Kinase Phosphatases | 1 | 2015 | 2 | 0.030 |
Why?
| Interviews as Topic | 2 | 2008 | 704 | 0.030 |
Why?
| MAP Kinase Kinase Kinase 2 | 1 | 2015 | 12 | 0.030 |
Why?
| Mitogen-Activated Protein Kinase 14 | 1 | 2015 | 6 | 0.030 |
Why?
| Mitogen-Activated Protein Kinase 8 | 1 | 2015 | 15 | 0.030 |
Why?
| Prospective Studies | 2 | 2013 | 7135 | 0.030 |
Why?
| ROC Curve | 1 | 2016 | 503 | 0.030 |
Why?
| Dual-Specificity Phosphatases | 1 | 2015 | 11 | 0.030 |
Why?
| Meat | 1 | 2016 | 93 | 0.030 |
Why?
| Immune System | 1 | 2016 | 175 | 0.030 |
Why?
| Hospitalization | 1 | 2024 | 2057 | 0.030 |
Why?
| Suppressor of Cytokine Signaling 1 Protein | 1 | 2014 | 12 | 0.030 |
Why?
| Dietary Fiber | 1 | 2015 | 51 | 0.030 |
Why?
| Population Groups | 1 | 2015 | 60 | 0.030 |
Why?
| Janus Kinase 1 | 1 | 2014 | 24 | 0.030 |
Why?
| Suppressor of Cytokine Signaling Proteins | 1 | 2014 | 21 | 0.030 |
Why?
| MAP Kinase Kinase Kinases | 1 | 2015 | 70 | 0.030 |
Why?
| Janus Kinase 2 | 1 | 2014 | 32 | 0.030 |
Why?
| Electrophoresis, Gel, Pulsed-Field | 1 | 2014 | 21 | 0.030 |
Why?
| STAT1 Transcription Factor | 1 | 2014 | 69 | 0.030 |
Why?
| Quantitative Trait Loci | 1 | 2016 | 353 | 0.030 |
Why?
| Molecular Epidemiology | 1 | 2014 | 63 | 0.030 |
Why?
| Mitogen-Activated Protein Kinase 1 | 1 | 2015 | 184 | 0.030 |
Why?
| Hospitals, Community | 1 | 2014 | 48 | 0.030 |
Why?
| Sequence Analysis, RNA | 1 | 2016 | 427 | 0.030 |
Why?
| Repetitive Sequences, Nucleic Acid | 1 | 2014 | 112 | 0.030 |
Why?
| Genes, sis | 1 | 2013 | 1 | 0.030 |
Why?
| Fibroblast Growth Factor 1 | 1 | 2013 | 12 | 0.030 |
Why?
| Receptor, Fibroblast Growth Factor, Type 2 | 1 | 2013 | 24 | 0.030 |
Why?
| Genes, erbB-2 | 1 | 2013 | 28 | 0.030 |
Why?
| Folic Acid | 1 | 2015 | 184 | 0.030 |
Why?
| Matrix Metalloproteinase 1 | 1 | 2013 | 18 | 0.030 |
Why?
| Matrix Metalloproteinase 3 | 1 | 2013 | 26 | 0.030 |
Why?
| DNA, Neoplasm | 1 | 2013 | 157 | 0.030 |
Why?
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2013 | 84 | 0.030 |
Why?
| Nerve Growth Factors | 1 | 2013 | 73 | 0.030 |
Why?
| Matrix Metalloproteinase 2 | 1 | 2013 | 54 | 0.030 |
Why?
| Fibroblast Growth Factor 2 | 1 | 2013 | 82 | 0.030 |
Why?
| Vascular Endothelial Growth Factor Receptor-1 | 1 | 2013 | 71 | 0.030 |
Why?
| Nitric Oxide Synthase Type II | 1 | 2013 | 171 | 0.030 |
Why?
| Platinum | 1 | 2013 | 44 | 0.030 |
Why?
| Drug Interactions | 1 | 2014 | 395 | 0.030 |
Why?
| Peroxidase | 1 | 2013 | 175 | 0.030 |
Why?
| New Mexico | 1 | 2013 | 59 | 0.030 |
Why?
| Epidermal Growth Factor | 1 | 2013 | 169 | 0.030 |
Why?
| Arizona | 1 | 2013 | 78 | 0.030 |
Why?
| Molecular Typing | 1 | 2012 | 20 | 0.030 |
Why?
| Genomic Instability | 1 | 2013 | 48 | 0.030 |
Why?
| Matrix Metalloproteinase 9 | 1 | 2013 | 119 | 0.030 |
Why?
| Disease Susceptibility | 1 | 2014 | 334 | 0.030 |
Why?
| Heterozygote | 1 | 2013 | 275 | 0.020 |
Why?
| Energy Intake | 1 | 2015 | 462 | 0.020 |
Why?
| Catheterization | 1 | 2012 | 175 | 0.020 |
Why?
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2013 | 274 | 0.020 |
Why?
| Stress, Physiological | 1 | 2014 | 414 | 0.020 |
Why?
| Disease-Free Survival | 1 | 2013 | 646 | 0.020 |
Why?
| Smoking Cessation | 1 | 2015 | 408 | 0.020 |
Why?
| Academic Medical Centers | 1 | 2014 | 475 | 0.020 |
Why?
| Haplotypes | 1 | 2012 | 475 | 0.020 |
Why?
| Vascular Endothelial Growth Factor A | 1 | 2013 | 530 | 0.020 |
Why?
| Alleles | 1 | 2013 | 847 | 0.020 |
Why?
| Cell Movement | 2 | 2006 | 948 | 0.020 |
Why?
| Transcriptome | 1 | 2016 | 876 | 0.020 |
Why?
| Weaning | 1 | 2010 | 48 | 0.020 |
Why?
| Surveys and Questionnaires | 2 | 2015 | 5415 | 0.020 |
Why?
| Longitudinal Studies | 1 | 2016 | 2720 | 0.020 |
Why?
| Species Specificity | 1 | 2010 | 574 | 0.020 |
Why?
| Tocopherols | 1 | 2008 | 25 | 0.020 |
Why?
| Renal Dialysis | 1 | 2012 | 423 | 0.020 |
Why?
| Carotenoids | 1 | 2008 | 41 | 0.020 |
Why?
| Body Weight | 1 | 2013 | 940 | 0.020 |
Why?
| Vitamin A | 1 | 2008 | 55 | 0.020 |
Why?
| Diet Records | 1 | 2008 | 80 | 0.020 |
Why?
| Drug Resistance, Neoplasm | 1 | 2013 | 752 | 0.020 |
Why?
| Respiration, Artificial | 1 | 2012 | 613 | 0.020 |
Why?
| Confidence Intervals | 1 | 2008 | 317 | 0.020 |
Why?
| Ascorbic Acid | 1 | 2008 | 120 | 0.020 |
Why?
| Factor Analysis, Statistical | 1 | 2008 | 284 | 0.020 |
Why?
| Time Factors | 1 | 2017 | 6555 | 0.020 |
Why?
| Proteasome Endopeptidase Complex | 1 | 2007 | 149 | 0.020 |
Why?
| Attitude to Health | 1 | 2009 | 433 | 0.020 |
Why?
| Disease Progression | 1 | 2013 | 2627 | 0.020 |
Why?
| Extracellular Matrix | 1 | 2010 | 506 | 0.020 |
Why?
| Glutathione | 1 | 2007 | 348 | 0.020 |
Why?
| Ultraviolet Rays | 1 | 2007 | 382 | 0.010 |
Why?
| Mood Disorders | 1 | 2005 | 121 | 0.010 |
Why?
| Rats, Sprague-Dawley | 1 | 2010 | 2395 | 0.010 |
Why?
| Receptors, Estradiol | 1 | 2003 | 3 | 0.010 |
Why?
| Software Validation | 1 | 2003 | 9 | 0.010 |
Why?
| Motor Activity | 1 | 2008 | 676 | 0.010 |
Why?
| MEDLINE | 1 | 2003 | 20 | 0.010 |
Why?
| Oxidation-Reduction | 1 | 2007 | 1028 | 0.010 |
Why?
| Forecasting | 1 | 2005 | 361 | 0.010 |
Why?
| Arteriosclerosis | 1 | 2003 | 89 | 0.010 |
Why?
| Disease | 1 | 2003 | 95 | 0.010 |
Why?
| Feasibility Studies | 1 | 2006 | 869 | 0.010 |
Why?
| Databases, Genetic | 1 | 2003 | 230 | 0.010 |
Why?
| Tumor Cells, Cultured | 1 | 2004 | 943 | 0.010 |
Why?
| Cluster Analysis | 1 | 2003 | 482 | 0.010 |
Why?
| Data Interpretation, Statistical | 1 | 2003 | 337 | 0.010 |
Why?
| Double-Blind Method | 1 | 2006 | 1875 | 0.010 |
Why?
| Rats | 1 | 2010 | 5483 | 0.010 |
Why?
| Oligonucleotide Array Sequence Analysis | 1 | 2003 | 756 | 0.010 |
Why?
| Health Knowledge, Attitudes, Practice | 1 | 2009 | 1280 | 0.010 |
Why?
| Bipolar Disorder | 1 | 2003 | 235 | 0.010 |
Why?
| Comorbidity | 1 | 2005 | 1547 | 0.010 |
Why?
| Mice, Knockout | 1 | 2007 | 2881 | 0.010 |
Why?
| Gene Expression Profiling | 1 | 2006 | 1687 | 0.010 |
Why?
| Cell Line, Tumor | 1 | 2006 | 3186 | 0.010 |
Why?
| Gene Expression | 1 | 2003 | 1465 | 0.010 |
Why?
| Epithelial Cells | 1 | 2004 | 1075 | 0.010 |
Why?
| Aging | 1 | 2007 | 1778 | 0.010 |
Why?
| Exercise | 1 | 2008 | 1928 | 0.010 |
Why?
| Arthritis, Rheumatoid | 1 | 2003 | 1098 | 0.010 |
Why?
| Hypertension | 1 | 2003 | 1243 | 0.010 |
Why?
|
|
Hines's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|